Cargando…
Optimized Encapsulation of the FLAP/PGES-1 Inhibitor BRP-187 in PVA-Stabilized PLGA Nanoparticles Using Microfluidics
The dual inhibitor of the 5-lipoxygenase-activating protein (FLAP) and the microsomal prostaglandin E(2) synthase-1 (mPGES-1), named BRP-187, represents a promising drug candidate due to its improved anti-inflammatory efficacy along with potentially reduced side effects in comparison to non-steroida...
Autores principales: | Behnke, Mira, Vollrath, Antje, Klepsch, Lea, Beringer-Siemers, Baerbel, Stumpf, Steffi, A. Czaplewska, Justyna, Hoeppener, Stephanie, Werz, Oliver, S. Schubert, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699897/ https://www.ncbi.nlm.nih.gov/pubmed/33233853 http://dx.doi.org/10.3390/polym12112751 |
Ejemplares similares
-
Effect of Crystallinity on the Properties of Polycaprolactone Nanoparticles Containing the Dual FLAP/mPEGS-1 Inhibitor BRP-187
por: Vollrath, Antje, et al.
Publicado: (2021) -
Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity
por: Shkodra-Pula, Blerina, et al.
Publicado: (2020) -
Ethoxy acetalated dextran nanoparticles for drug delivery: A comparative study of formulation methods
por: Behnke, Mira, et al.
Publicado: (2023) -
BrpNAC895 and BrpABI449 coregulate the transcription of the afflux-type cadmium transporter BrpHMA2 in Brassica parachinensis
por: Liu, Shuai, et al.
Publicado: (2022) -
Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201
por: Kretzer, Christian, et al.
Publicado: (2022)